Overview
Masumi Ueda-Oshima is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Ueda-Oshima is rated as an Experienced provider by MediFind in the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH). Her top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Ueda-Oshima is currently accepting new patients.
Her clinical research consists of co-authoring 21 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- MANAGED MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- PPO
- EPO
- PPO
Locations
825 Eastlake Ave E, Seattle, WA 98109
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
The Association Of University Physicians
Bart Scott is an Oncologist in Seattle, Washington. Dr. Scott is rated as an Elite provider by MediFind in the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH). His top areas of expertise are Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Chronic Myelomonocytic Leukemia (CMML), Leukemia, and Bone Marrow Aspiration. Dr. Scott is currently accepting new patients.
Farnoush Abar is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Abar is rated as a Distinguished provider by MediFind in the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH). Her top areas of expertise are Waldenstrom Macroglobulinemia, Paget Disease of the Breast, Familial Pancreatic Cancer, and Pleuropulmonary Blastoma. Dr. Abar is currently accepting new patients.
The Association Of University Physicians
Edmond Marzbani is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Marzbani is rated as a Distinguished provider by MediFind in the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH). His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), and Posterior Fossa Tumor. Dr. Marzbani is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Myeloid Leukemia (AML)Dr. Ueda-Oshima isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Advanced
- Acute Myeloblastic Leukemia with MaturationDr. Ueda-Oshima isAdvanced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without Maturation
- Bone Marrow TransplantDr. Ueda-Oshima isAdvanced. Learn about Bone Marrow Transplant.
- Childhood Acute Myeloid LeukemiaDr. Ueda-Oshima isAdvanced. Learn about Childhood Acute Myeloid Leukemia.
- Multiple MyelomaDr. Ueda-Oshima isAdvanced. Learn about Multiple Myeloma.
- Myelodysplastic Syndrome (MDS)Dr. Ueda-Oshima isAdvanced. Learn about Myelodysplastic Syndrome (MDS).
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Ueda-Oshima isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Monoblastic Leukemia (AmoL)Dr. Ueda-Oshima isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- AgranulocytosisDr. Ueda-Oshima isExperienced. Learn about Agranulocytosis.
- Aplastic AnemiaDr. Ueda-Oshima isExperienced. Learn about Aplastic Anemia.
- Bone Marrow AspirationDr. Ueda-Oshima isExperienced. Learn about Bone Marrow Aspiration.
- Chronic B-Cell Leukemia (CBCL)Dr. Ueda-Oshima isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).